To confirm our hypothesis that increased activation of the AKT-mTOR signalling pathway caused the MPD symptoms in CD11c LAMTOR2del mice, we treated the knockout and control animals with 30 μg Rapamycin for 10 days24, 25. Here, MTOR is linked to myeloproliferative disorder.